Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Bokang Bioengineering is a prominent Chinese biotechnology company specializing in the development, manufacture, and sale of in vitro diagnostic (IVD) reagents. Established in 1992, the company is a leader in the field of immunohematology, particularly known for its high-quality blood grouping monoclonal antibodies and diagnostic kits for infectious diseases. Its product portfolio includes ABO and Rh blood typing reagents, as well as screening tools for syphilis, hepatitis, and HIV. The company operates a large-scale manufacturing facility in Shanghai and serves hospitals, blood banks, and clinical laboratories across China and international markets. Bokang was among the first in its sector to achieve GMP certification in China, underscoring its commitment to quality and regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Bokang Bioengineering.